GLUE peer analysis
Monte Rosa Therapeutics (GLUE) against its competitors: price, today's move, 1-year return and market value side by side.
GLUE and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ARVN Arvinas | $6.39 | -2.44% | -31.56% | $485.90M |
| CCCC C4 Therapeutics | $3.14 | 6.44% | 24.47% | – |
| NRIX Nurix Therapeutics | $15.07 | 1.55% | 19.15% | – |
| GLUE Monte Rosa Therapeutics | $10.57 | 3.12% | -14.30% | – |
- GLUE's peers: ARVN (Arvinas), CCCC (C4 Therapeutics), NRIX (Nurix Therapeutics).
Updated 2026-11-07 11:54 UTC